Literature DB >> 30632526

The Influence of Concomitant Disorders on Disease Severity of Familial Mediterranean Fever in Children.

Rabia Miray Kişla Ekinci1, Sibel Balci1, Derya Ufuk Altintaş2, Mustafa Yilmaz1.   

Abstract

OBJECTIVES: This study aims to describe the effects of concomitant disorders on the course of familial Mediterranean fever (FMF) and the relevance of genotype on these associations. PATIENTS AND METHODS: Files of 494 FMF patients (257 males, 237 females; mean age 12.8±1.94 years; range 1.6 to 23 years) were retrospectively examined. Age of diagnosis, sex, MEditerrenean FeVer mutations, colchicine dosage, disease severity score and concomitant diseases in FMF course were recorded. FMF diagnoses were based on Tel-Hashomer criteria and disease severity was determined by international severity scoring system for FMF. Patients were divided into two groups as M694V positives and M694V negatives. We compared the groups in terms of accompanying illnesses, MEditerrenean FeVer mutations, and disease severity scores among five concomitant diseases: juvenile idiopathic arthritis (JIA), asthma, Henoch- Schonlein purpura, periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome, and others.
RESULTS: The mean age at diagnosis was 8.7±1.9 years. Eighty-five patients (17.2%) had accompanying diseases including JIA, asthma, periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome, and Henoch-Schonlein purpura. Mean disease severity scores were 2.4±1.1 in patients with only FMF and 3.0±1.5 in patients with concomitant disorders (p=0.001). Patients with concomitant JIA showed the highest severity scores (4.3±1.6). A statistically significant difference was found with one-way analysis of variance.
CONCLUSION: Our findings indicate that concomitant diseases, particularly JIA, influence FMF severity. Therefore, it may be beneficial to focus on diagnosis and treatment of comorbid inflammatory diseases, which may worsen the course of FMF.

Entities:  

Keywords:  Children; concomitant; familial Mediterranean fever; severity

Year:  2017        PMID: 30632526      PMCID: PMC6328214          DOI: 10.5606/ArchRheumatol.2018.6488

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  25 in total

1.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

2.  Infliximab therapy in a patient with familial Mediterranean fever and chronic hip arthritis.

Authors:  Serdar Daysal; Gulhan Akcil; Berna Goker; Seminur Haznedaroglu; Nil Ercan; Mehmet Akif Ozturk
Journal:  Arthritis Rheum       Date:  2005-02-15

3.  The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.

Authors:  M Centola; G Wood; D M Frucht; J Galon; M Aringer; C Farrell; D W Kingma; M E Horwitz; E Mansfield; S M Holland; J J O'Shea; H F Rosenberg; H L Malech; D L Kastner
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

4.  Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever.

Authors:  O Sakallioglu; A Duzova; S Ozen
Journal:  Clin Exp Rheumatol       Date:  2006 Jul-Aug       Impact factor: 4.473

5.  Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.

Authors:  Mehmet Tunca; Servet Akar; Fatos Onen; Huri Ozdogan; Ozgur Kasapcopur; Fatos Yalcinkaya; Ercan Tutar; Seza Ozen; Rezan Topaloglu; Engin Yilmaz; Mustafa Arici; Aysin Bakkaloglu; Nesrin Besbas; Tekin Akpolat; Ayhan Dinc; Eren Erken
Journal:  Medicine (Baltimore)       Date:  2005-01       Impact factor: 1.889

6.  Crohn disease in patients with familial Mediterranean fever.

Authors:  Herma H Fidder; Yehuda Chowers; Merav Lidar; Matan Sternberg; Pnina Langevitz; Avi Livneh
Journal:  Medicine (Baltimore)       Date:  2002-11       Impact factor: 1.889

7.  Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa.

Authors:  Fatoş Yalçinkaya; Z Birsin Ozçakar; Ozgür Kasapçopur; Ayşenur Oztürk; Nejat Akar; Ayşin Bakkaloğlu; Nil Arisoy; Mesiha Ekim; Seza Ozen
Journal:  J Pediatr       Date:  2007-08-28       Impact factor: 4.406

8.  MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura.

Authors:  Z Birsin Ozçakar; Fatos Yalçinkaya; Nilgün Cakar; Banu Acar; Ozgür Kasapçopur; Deniz Ugüten; Derya Soy; Nazli Kara; Nermin Uncu; Nil Arisoy; Mesiha Ekim
Journal:  J Rheumatol       Date:  2008-10-01       Impact factor: 4.666

Review 9.  The arthritis of familial Mediterranean fever.

Authors:  A Garcia-Gonzalez; M H Weisman
Journal:  Semin Arthritis Rheum       Date:  1992-12       Impact factor: 5.532

10.  Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura.

Authors:  Ruth Gershoni-Baruch; Yiftah Broza; Riva Brik
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

View more
  8 in total

1.  Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis.

Authors:  Rabia Miray Kisla Ekinci; Sibel Balci; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

2.  Evaluation of co-existing diseases in children with familial Mediterranean fever.

Authors:  Mehmet Yildiz; Amra Adrovic; Emre Tasdemir; Khanim Baba-Zada; Muhammed Aydin; Oya Koker; Sezgin Sahin; Kenan Barut; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2019-07-27       Impact factor: 2.631

3.  Case Report: A Pediatric Case of Familial Mediterranean Fever Concurrent With Autoimmune Hepatitis.

Authors:  Mariko Aoki; Kazushi Izawa; Takayuki Tanaka; Yoshitaka Honda; Takeshi Shiba; Yukako Maeda; Takayuki Miyamoto; Keisuke Okamoto; Masahiko Nishitani-Isa; Hiroshi Nihira; Kohsuke Imai; Junko Takita; Ryuta Nishikomori; Eitaro Hiejima; Takahiro Yasumi
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

4.  Juvenile idiopathic arthritis in a center in the Western Anatolia region in Turkey.

Authors:  Gülçin Otar Yener; Zahide Ekici Tekin; İlknur Girişgen; Ebru Nevin Çetin; Beyza Akdağ; Selçuk Yüksel
Journal:  Turk Pediatri Ars       Date:  2020-06-19

5.  Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort.

Authors:  Hatice Bodur; Fatma Gül Yurdakul; Hasan Fatih Çay; Ülkü Uçar; Yaşar Keskin; Betül Sargın; Gülcan Gürer; Ozan Volkan Yurdakul; Mustafa Çalış; Hülya Deveci; Yıldıray Aydın; Sami Hizmetli; Remzi Çevik; Ali Yavuz Karahan; İsmihan Sunar; Mehmet Tuncay Duruöz; Hilal Ecesoy; Zafer Günendi; Murat Toprak; Nesrin Şen; Duygu Altıntaş; Ahmet Kıvanç Cengiz; Gökhan Çağlayan; Ali Nail Demir; Hüseyin Kaplan; Sertaç Ketenci; Meltem Alkan Melikoğlu; Mehmet Nayimoğlu; Kemal Nas; Ayşe Banu Sarıfakıoğlu; İlhan Sezer
Journal:  Rheumatol Int       Date:  2019-09-14       Impact factor: 2.631

6.  The contribution of diet preference to the disease course in children with familial Mediterranean fever: a cross-sectional study.

Authors:  Rabia Miray Kisla Ekinci; Sibel Balci; Atıl Bisgin; Fatma Tugba Cetin; Gokhan Tumgor
Journal:  Reumatologia       Date:  2020-04-30

7.  Familial Mediterranean Fever Mutation Analysis in Pediatric Patients With İnflammatory Bowel Disease: A Multicenter Study.

Authors:  Nafiye Urgancı; Funda Ozgenc; Zarife Kuloğlu; Hasan Yüksekkaya; Sinan Sarı; Tülay Erkan; Zerrin Önal; Gönül Çaltepe; Mustafa Akçam; Duran Arslan; Nur Arslan; Reha Artan; Ayşen Aydoğan; Necati Balamtekin; Maşallah Baran; Gökhan Baysoy; Murat Çakır; Buket Dalgıç; Yaşar Doğan; Özlem Durmaz; Çiğdem Ecevıt; Makbule Eren; Selim Gökçe; Fulya Gülerman; Figen Gürakan; Samil Hızlı; Ishak Işık; Ayhan Gazi Kalaycı; Aydan Kansu; Tufan Kutlu; Hamza Karabiber; Erhun Kasırga; Günsel Kutluk; Ferdağ Özbay Hoşnut; Hasan Özen; Tanju Özkan; Yeşim Öztürk; Özlem Bekem Soylu; Engin Tutar; Gökhan Tümgör; Fatih Ünal; Meltem Ugraş; Gonca Üstündağ; Aytaç Yaman; Turkish Ibd Study Group
Journal:  Turk J Gastroenterol       Date:  2021-03       Impact factor: 1.852

8.  Prediction of More Severe MEFV Gene Mutations in Childhood.

Authors:  Seviye Güneş-Yılmaz; Belde Kasap-Demir; Eren Soyaltın; Gökçen Erfidan; Özgür Özdemir-Şimşek; Seçil Arslansoyu-Çamlar; Demet Alaygut; Fatma Mutlubaş
Journal:  Turk Arch Pediatr       Date:  2021-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.